Phase II Trial of Simple Oral Therapy with Capecitabine and Cyclophosphamide in Patients with Metastatic Breast Cancer: SWOG S0430

BACKGROUND. Interest in oral agents for the treatment of metastatic breast cancer (MBC) has increased because many patients prefer oral to i.v. regimens. We evaluated a simple oral combination of capecitabine with cyclophosphamide (CPA) for MBC. METHODS. The trial was designed to determine whether o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Schott, Anne F., Barlow, William E., Albain, Kathy S., Chew, Helen K., Wade, James L., Lanier, Keith S., Lew, Danika L., Hayes, Daniel F., Gralow, Julie R., Livingston, Robert B., Hortobagyi, Gabriel N.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2012
Sujets:
Breast Cancer
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3286166/
https://ncbi.nlm.nih.gov/pubmed/22267853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0235
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires